rs41548013
Variant names:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001330360.2(POLA1):āc.3622G>Cā(p.Asp1208His) variant causes a missense change. The variant allele was found at a frequency of 0.00705 in 1,204,526 control chromosomes in the GnomAD database, including 32 homozygotes. There are 2,709 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0040 ( 1 hom., 132 hem., cov: 23)
Exomes š: 0.0074 ( 31 hom. 2577 hem. )
Consequence
POLA1
NM_001330360.2 missense
NM_001330360.2 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 5.23
Genes affected
POLA1 (HGNC:9173): (DNA polymerase alpha 1, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase, which together with a regulatory and two primase subunits, forms the DNA polymerase alpha complex. The catalytic subunit plays an essential role in the initiation of DNA replication. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.007820755).
BP6
Variant X-24826487-G-C is Benign according to our data. Variant chrX-24826487-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 587618.We mark this variant Likely_benign, oryginal submissions are: {Benign=2, Uncertain_significance=1}. Variant chrX-24826487-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00401 (448/111689) while in subpopulation NFE AF= 0.00705 (375/53175). AF 95% confidence interval is 0.00646. There are 1 homozygotes in gnomad4. There are 132 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 132 XL gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00401 AC: 448AN: 111634Hom.: 1 Cov.: 23 AF XY: 0.00390 AC XY: 132AN XY: 33816
GnomAD3 genomes
AF:
AC:
448
AN:
111634
Hom.:
Cov.:
23
AF XY:
AC XY:
132
AN XY:
33816
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00396 AC: 710AN: 179133Hom.: 2 AF XY: 0.00369 AC XY: 236AN XY: 63875
GnomAD3 exomes
AF:
AC:
710
AN:
179133
Hom.:
AF XY:
AC XY:
236
AN XY:
63875
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00736 AC: 8043AN: 1092837Hom.: 31 Cov.: 27 AF XY: 0.00719 AC XY: 2577AN XY: 358409
GnomAD4 exome
AF:
AC:
8043
AN:
1092837
Hom.:
Cov.:
27
AF XY:
AC XY:
2577
AN XY:
358409
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00401 AC: 448AN: 111689Hom.: 1 Cov.: 23 AF XY: 0.00390 AC XY: 132AN XY: 33881
GnomAD4 genome
AF:
AC:
448
AN:
111689
Hom.:
Cov.:
23
AF XY:
AC XY:
132
AN XY:
33881
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
33
ALSPAC
AF:
AC:
22
ESP6500AA
AF:
AC:
7
ESP6500EA
AF:
AC:
51
ExAC
AF:
AC:
486
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
X-linked reticulate pigmentary disorder Uncertain:1
Aug 07, 2018
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not specified Benign:1
May 04, 2022
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.;D
REVEL
Benign
Sift
Uncertain
D;.;D
Sift4G
Uncertain
D;D;D
Polyphen
0.95
.;.;P
Vest4
MVP
MPC
0.98
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at